Research suggests that semaglutide, the active ingredient in the weight-loss medication Wegovy, may help lower migraine severity. The findings indicate that women may experience more pronounced benefits than men. This discovery could have implications for migraine management strategies, though further research is needed to understand the mechanisms involved.
Weight & Metabolism · Jun 18, 2026 · 17 hours ago
Semaglutide may reduce migraine severity, particularly in women
Read the full story at healthline.com →
This summary was prepared by the HealthyFreePress editorial desk; the underlying reporting belongs to the linked publisher. Nothing here is medical advice — see our Medical Disclaimer and Editorial Policy.